The Benefits of Calcium, Diabetes Treatment

Calcium plays a crucial role in maintaining overall health, including the regulation of blood sugar levels. Several studies have examined the potential benefits of Calcium intake in preventing or managing Diabetes According to current medical research, Calcium may indeed have a positive impact on Diabetes prevention and control.

One study conducted on a large cohort of middle-aged adults showed that higher Calcium intake was associated with a reduced risk of developing type 2 Diabetes Researchers found that individuals who consumed more Calcium from both dietary sources and supplements had a lower incidence of Diabetes compared to those with lower Calcium intake. Calcium's potential mechanisms in preventing Diabetes include its involvement in insulin secretion and sensitivity, as well as its impact on beta-cell function, which are vital for blood sugar regulation.

Furthermore, some studies suggest that Calcium supplementation in individuals with Diabetes may have potential benefits. For instance, research indicates that Calcium supplementation can improve insulin sensitivity in those with metabolic syndrome, a cluster of conditions including obesity, high blood pressure, and insulin resistance, which often precedes type 2 Diabetes However, more research is needed to fully understand the potential benefits of Calcium supplementation in individuals with Diabetes

In conclusion, current medical research indicates that Calcium may play a beneficial role in preventing the development of type 2 Diabetes and improving blood sugar control. However, it is worth noting that Calcium supplementation should be approached with caution and under the guidance of a healthcare professional, as excessive Calcium intake can have adverse effects. Consulting with a healthcare provider and maintaining a balanced diet that includes calcium-rich foods can be a wise approach to prioritize overall health and potentially aid in Diabetes prevention or management.

 Description

 1 Review mentioning 'Diabetes'.

Supplement: , Used for treating Diabetes

Slow Fe has a controlled delivery system that provides high potency
iron while being gentle on your stomach, so you experience fewer GI
side effects (nausea and abdominal discomfort) common to iron use.
Slow Fe is an iron supplement for iron deficiency and iron deficiency anemia
when the need for such therapy has been determined by a physician. Iron
deficiency is most common among women (approximately 12% of US women).
Supplement Facts
Serving Size 1 Tablet
Amount Per Serving % Daily Value
lron (elemental) 45 mg 250%
Ingredients: ferrous sulfate USP, dibasic calcium phosphate, silicified
microcrystalline cellulose, hypromellose, carbomer homopolymer, ascorbic acid
(preservative), magnesium stearate, tribasic calcium phosphate, polyvinyl alcohol,
polyethylene glycol, talc, titanium dioxide, red 40 lake, yellow 6 lake, blue 1 lake
The 45 mg of elemental iron in each tablet is equivalent to 137 mg of ferrous sulfate.
The treatment of iron deficiency anemia should be under the advice and supervision of a doctor.
Directions: Adults: Take 1 tablet daily, or as recommended by a doctor. Tablets must be
swallowed whole. Not intended for use in children.
Do not use:
0 if you are taking other supplements containing iron
v for more than six months unless directed by your doctor
Consult a doctor before use if you are pregnant or nursing.
Oral iron supplements:
- may interfere with absorption of certain oral antibiotics (e.g., tetracycline) and other
medications. These products should not be taken within two (2) hours of each other.
- may cause occasional bowel effects such as constipation
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal
poisoning in children under 6. Keep this product out of reach of children. In case of
accidental overdose, call a doctor or Poison Control Center immediately.
Distributed by: GSK Consumer Healthcare, Warren, NJ 07059
Trademarks are owned by or licensed to the GSK group of companies.
©2020 GSK group of companies or its licensor. 13507
image